Market Cap: $1.61B
TI
Taysha Gene Therapies, Inc.
TSHA
NASDAQ (NASDAQ Global Select)USD
Market Cap: $1.61B
Analysts estimated TSHA earnings of $-0.12 per share this quarter (Q2). TSHA's actual earnings were $-0.14 per share.
TSHA EPS surprise of -17.75%Analysts estimated TSHA earnings of $-0.10 per share this quarter (Q1). TSHA's actual earnings were $-0.12 per share.
TSHA EPS surprise of -20.48%Analysts estimated TSHA earnings of $-0.10 per share this quarter (Q4). TSHA's actual earnings were $-0.08 per share.
TSHA EPS surprise of 18.45%Analysts estimated TSHA earnings of $-0.08 per share this quarter (Q2). TSHA's actual earnings were $-0.09 per share.
TSHA EPS surprise of -9.09%Analysts estimated TSHA earnings of $-0.09 per share this quarter (Q1). TSHA's actual earnings were $-0.08 per share.
TSHA EPS surprise of 15.25%Analysts estimated TSHA earnings of $-0.08 per share this quarter (Q4). TSHA's actual earnings were $-0.07 per share.
TSHA EPS surprise of 17.36%Analysts estimated TSHA earnings of $-0.09 per share this quarter (Q3). TSHA's actual earnings were $-0.10 per share.
TSHA EPS surprise of -5.82%Analysts estimated TSHA earnings of $-0.17 per share this quarter (Q2). TSHA's actual earnings were $-0.09 per share.
TSHA EPS surprise of 46.40%Analysts estimated TSHA earnings of $-0.11 per share this quarter (Q1). TSHA's actual earnings were $-0.10 per share.
TSHA EPS surprise of 10.39%Analysts estimated TSHA earnings of $-0.11 per share this quarter (Q4). TSHA's actual earnings were $0.92 per share.
TSHA EPS surprise of -919.96%Analysts estimated TSHA earnings of $-0.18 per share this quarter (Q3). TSHA's actual earnings were $-0.13 per share.
TSHA EPS surprise of -26.22%